Status:

NOT_YET_RECRUITING

Endoscopic Cardial Constriction Ligation (ECCL) for Refractory GERD Using a Disposable Endoscope

Lead Sponsor:

Ying Zhu

Conditions:

Gastroesophageal Reflux Disease (GERD)

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This study will recruit patients aged 18-80 with refractory gastroesophageal reflux disease (GERD). These patients had a disease course of more than six months, experienced typical symptoms such as ac...

Detailed Description

Gastroesophageal reflux disease (GERD) is a common digestive disorder, with endoscopic manifestations including non-erosive reflux disease (NERD), reflux esophagitis (RE), and Barrett's esophagus (BE)...

Eligibility Criteria

Inclusion

  • (1) Age 18-80 years;
  • (2) Disease duration ≥6 months, with typical symptoms such as acid regurgitation and heartburn, and a confirmed diagnosis of GERD;
  • (3) GERD patients whose symptoms are not relieved after 8 weeks of continuous double-dose acid-suppressive therapy;
  • (4) Willing to participate in the study and have signed the informed consent form.

Exclusion

  • (1) Patients with precancerous lesions such as early esophageal cancer or Barrett's esophagus \>3 cm, or advanced upper gastrointestinal cancer identified on endoscopy;
  • (2) Patients with hiatal hernia ≥2 cm, severe reflux esophagitis (LA-C or LA-D grade), esophageal or gastric varices, esophageal ulcer or stenosis, or a history of esophageal or gastric surgery;
  • (3) Patients with esophageal motility disorders such as achalasia or diffuse esophageal spasm, rheumatic diseases such as systemic sclerosis or Sjögren's syndrome, or eosinophilic esophagitis;
  • (4) Patients with a history of endoscopic or surgical anti-reflux procedures;
  • (5) Patients with coagulation disorders, severe cardiopulmonary diseases, or inability to tolerate anesthesia, endoscopy, or treatment;
  • (6) Women in the puerperium.

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2028

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT07176221

Start Date

October 1 2025

End Date

June 30 2028

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shenzhen Hospital of Southern Medical University

Shenzhen, Guangdong, China, 510515